Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06655883
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-22
Brief Title:
A Study of Suvorexant MK-4305 for the Treatment of Insomnia in Participants With Opioid Use Disorder MK-4305-098
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 3 Multicenter Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Suvorexant for the Treatment of Insomnia in Participants With Opioid Use Disorder
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
People with opioid use disorder OUD can have trouble falling or staying asleep Researchers want to know if suvorexant will help people with OUD fall asleep and stay asleep The goal of this study is to learn about the safety of suvorexant and how well people tolerate it Researchers also want to learn if suvorexant helps people sleep longer compared to people who take placebo A placebo looks like the study medicine but has no actual study medicine in it
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None